Q2 2016 Holdings
Filed 2016-08-10 | 91 holdings | $23.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $3.0K | 150,716 | 0.0% |
| Sage Therapeutics IncCall | CALL | 78667J908 | $3.0K | 1,000 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $3.3K | 90,000 | 0.0% |
| Alnylam Pharmaceuticals IncPut | PUT | 02043Q957 | $3.3K | 600 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $3.5K | 130,000 | 0.0% |
| B Communications LTD | SHS | M15629104 | $3.6K | 148,861 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $3.7K | 40,000 | 0.0% |
| Keryx Biopharmaceuticals Inc | COM | 492515101 | $3.7K | 562,900 | 0.0% |
| Tesaro IncCall | CALL | 881569907 | $3.8K | 450 | 0.0% |
| Colucid Pharmaceuticals Inc | COM | 19716T101 | $4.1K | 500,137 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $4.1K | 270,000 | 0.0% |
| Gilead Sciences IncCall | CALL | 375558903 | $4.2K | 500 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $4.2K | 258,513 | 0.0% |
| Advance Auto Parts Inc(AAP) | COM | 00751Y106 | $4.5K | 27,662 | 0.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $4.6K | 325,053 | 0.0% |
| Achaogen Inc | COM | 4449104 | $4.8K | 1,257,366 | 0.0% |
| Acadia Healthcare Company inCall | CALL | 00404A909 | $4.9K | 1,500 | 0.0% |
| Alexion Pharmaceuticals Inc | COM | 15351109 | $4.9K | 42,323 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $5.0K | 57,600 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $5.1K | 105,000 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $5.2K | 718,080 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $5.5K | 1,005,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.8K | 100,000 | 0.0% |
| Biogen IncPut | PUT | 09062X953 | $6.0K | 250 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $6.4K | 398,287 | 0.0% |
| Ituran Location and Control(ITRN) | SHS | M6158M104 | $10.4K | 460,452 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $10.8K | 250,000 | 0.0% |
| Amgen Inc | COM | 31162100 | $12.9K | 85,000 | 0.1% |
| Pfizer Inc(PFE) | COM | 717081103 | $15.0K | 426,612 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $15.3K | 155,000 | 0.1% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $15.8K | 200,000 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $16.1K | 192,700 | 0.1% |
| Shire PLC | SPONSORED ADR | 82481R106 | $21.6K | 264,539 | 0.1% |
| Allergan PLC | SHS | G0177J108 | $22.0K | 95,000 | 0.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | ADR | 881624209 | $30.1K | 600,200 | 0.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $304.0K | 32,069 | 1.3% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $1.0M | 300,000 | 4.5% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $2.1M | 368,500 | 9.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $3.5M | 261,800 | 15.0% |
| Charter Communications Inc N(CHTR) | CL A | 16119P108 | $3.7M | 16,065 | 15.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $12.2M | 50,500 | 52.7% |